Page last updated: 2024-11-10

mycoversilin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

mycoversilin: isolated from a mutant derivative of Aspergillus versicolor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3036427
MeSH IDM0121018

Synonyms (6)

Synonym
8,11-dimethylpyrano(3,2-a)xanthene-1,5,6,9,10,12-hexol
mycoversilin
pyrano(3,2-a)xanthene-1,5,6,9,10,12-hexol, 8,11-dimethyl-
8,11-dimethyl-1,12-dihydropyrano[3,2-a]xanthene-1,5,6,9,10,12-hexol
88527-18-8
DTXSID401008215

Research Excerpts

Overview

Mycoversilin is a narrow spectrum antibiotic with activity against filamentous fungi. It is a unique polynuclear aromatic compound having two methyl and six hydroxyl groups and two ether linkages.

ExcerptReferenceRelevance
"Mycoversilin is a narrow spectrum antibiotic with activity against filamentous fungi, particularly Trichophyton rubrum (MIC 15 micrograms/ml)."( Mycoversilin, a new antifungal antibiotic. I. Fermentation, isolation and biological properties.
Bose, SK; Samanta, AK, 1984
)
2.43
"Mycoversilin is a unique polynuclear aromatic compound having two methyl and six hydroxyl groups and two ether linkages."( Mycoversilin, a new antifungal antibiotic. II. Structure elucidation.
Bose, SK; Mahato, SB; Samanta, AK, 1984
)
2.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]